Literature DB >> 16960292

Paradoxically accelerated fatal brain herniation following thrombolytic therapy in acute ischemic stroke.

Sang Won Han1, Seo Hyun Kim, Ha Young Shin, Hye Yeon Choi, Chan Hee Park, Jin Kwon Kim, Ji Hoe Heo.   

Abstract

INTRODUCTION: The use of plasminogen activators (PAs) in acute stroke patients has dual effects. PAs are beneficial by dissolving thrombi occluding an artery, but may be harmful by their proteolytic and excitotoxic actions. METHODS AND
RESULTS: We report two patients with a fatal brain herniation who rapidly deteriorated despite the successful recanalization and the sustained arterial patency or blood flow. Imaging studies taken after the thrombolytic treatment suggested early occurrence of cellular damage and profound breakdown of the blood-brain barrier.
CONCLUSION: Fatal brain edema occurred after persistent reperfusion by the thrombolytic therapy. Paradoxical thrombolytic-induced injury, which has been suggested in experimental studies, might play a role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960292     DOI: 10.1385/NCC:5:1:35

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  17 in total

Review 1.  Cerebral hyperperfusion syndrome.

Authors:  Walther N K A van Mook; Roger J M W Rennenberg; Geert Willem Schurink; Robert Jan van Oostenbrugge; Werner H Mess; Paul A M Hofman; Peter W de Leeuw
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

2.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

3.  Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.

Authors:  Kyung Yul Lee; Dong Ik Kim; Seo Hyun Kim; Seung Ik Lee; Hae Woong Chung; Yong Woon Shim; Seung Min Kim; Ji Hoe Heo
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

4.  Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.

Authors:  Nobuo Nagai; Bing-Qiao Zhao; Yasuhiro Suzuki; Hayato Ihara; Tetsumei Urano; Kazuo Umemura
Journal:  J Cereb Blood Flow Metab       Date:  2002-06       Impact factor: 6.200

5.  Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.

Authors:  Yasemin Gürsoy-Ozdemir; Alp Can; Turgay Dalkara
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

Review 6.  The neurotoxicity of tissue plasminogen activator?

Authors:  Jaspreet Kaur; Zonghang Zhao; Gary M Klein; Eng H Lo; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2004-09       Impact factor: 6.200

7.  Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.

Authors:  Ji Hoe Heo; Kyung Yul Lee; Seo Hyun Kim; Dong Ik Kim
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

8.  Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.

Authors:  Xiaoying Wang; Sun-Ryung Lee; Ken Arai; Seong-Ryong Lee; Kiyoshi Tsuji; G William Rebeck; Eng H Lo
Journal:  Nat Med       Date:  2003-09-07       Impact factor: 53.440

9.  Incidence of space-occupying brain edema following systemic thrombolysis of acute supratentorial ischemia.

Authors:  J Rudolf; M Grond; C Stenzel; M Neveling; W D Heiss
Journal:  Cerebrovasc Dis       Date:  1998 May-Jun       Impact factor: 2.762

10.  Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke.

Authors:  P J Koudstaal; J Stibbe; M Vermeulen
Journal:  BMJ       Date:  1988-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.